Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) announces the start of metallurgical testing on cobalt...
-
Mobilicom’s BlueUAS listed SkyHopper PRO software-defined radios and advanced OS3cybersecurity software are fully integrated with ARK’s made-in-USA, BlueUAS listed Jetson PAB Carrier, powered by...
-
CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...
-
Diversified business model fuels outperformance Second quarter and year to date operating highlights: Three months ended Six months ended June 30 June 30(in millions of US$, except...
-
Aduro explores chemical recycling of synthetic turf waste, showcasing HCT’s ability to handle complex materials underserved by traditional methods.
-
ATHENS, Greece, July 31, 2025 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (the “Company,” “CCEC”, “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessels, today...
-
Balchem Corporation Reports Second Quarter 2025 Financial Results
-
Q2 2025 Total Revenue of $154.7M, up 18% at CER Galafold® Q2 Revenue of $128.9M, up 12% at CER Pombiliti® + Opfolda® Q2 Revenue of $25.8M, up 58% at CER Reiterating 2025 Financial...
-
CORAL GABLES, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for...
-
Total revenue was €51.4 mm in Q2 2025, while net gaming revenue1 was €54.8 mm in the period, 1% above Q2 2024 (12% in constant currency terms).Mexico revenue was €26.3 mm in Q2 2025, while net...